2617 A Prospective Randomized Phase-II Trial with Temsirolimus vs. Sunitinib in non-clear Renal Cell Carcinoma. A Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and Interdisciplinary Renal Cell Carcinoma Group of the German Cancer Society (IAGN). (September 2015)

• Record Type: Journal Article
• Authors: Bergmann, L.; Grünwald, V.; Maute, L.; Grimm, M.O.; Weikert, S.; Schleicher, J.; Klotz, T.; Greiner, J.; Westermann, J.; Hartmann, A.; Moritz, B.; Gauler, T.
• Is Part Of: European journal of cancer. Volume 51:(2015)Supplement 3
• Page Start: S517
• Publication Date: 2015-09
• Subjects: Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Cancer; Tumors; Electronic journals; Periodicals; Electronic journals; 616.994
• DOI: 10.1016/S0959-8049(16)31435-6
• Languages: English
• ISSNs: 0959-8049